The specificity of omeprazole as an (H++K+)-ATPase inhibitor depends upon the means of its activation
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (3), 339-344
- https://doi.org/10.1016/0006-2952(87)90291-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The preparation of 14C, 35S and 13C labelled forms of omeprazoleJournal of Labelled Compounds and Radiopharmaceuticals, 1986
- Acid activation of (H+–K+)-ATPase inhibiting 2-(2-pyridylmethyl-sulphinyl)benzimidazoles: isolation and characterization of the thiophilic ‘active principle’ and its reactionsJournal of the Chemical Society, Chemical Communications, 1986
- Studies on the mechanism of action of omeprazoleBiochemical Pharmacology, 1985
- The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazoleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cellBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Inhibition of (Biochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- The catalytic cycle of gastric (H+ + K+)-ATPase.Journal of Biological Chemistry, 1980
- On the reversibility of binding of cardiotonic steroids to a partially purified (Na + K)-activated adenosinetriphosphatase from beef brainBiochemical and Biophysical Research Communications, 1970
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951